P/E ratio for Illumina (ILMN)
P/E ratio as of June 2024 (TTM): -3.80
According to Illumina's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -3.79744. At the end of 2022 the company had a P/E ratio of -7.22.
P/E ratio history for Illumina from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -7.22 | -109.66% |
| 2021 | 74.7 | -9.5% |
| 2020 | 82.6 | 69.54% |
| 2019 | 48.7 | -8.72% |
| 2018 | 53.4 | 21.15% |
| 2017 | 44.1 | 8.72% |
| 2016 | 40.5 | -32.66% |
| 2015 | 60.2 | -16.22% |
| 2014 | 71.8 | -35.06% |
| 2013 | 111 | 142.71% |
| 2012 | 45.6 | 6.14% |
| 2011 | 42.9 | -31.55% |
| 2010 | 62.7 | 20.6% |
| 2009 | 52.0 | -31.13% |
| 2008 | 75.5 | -761.29% |
| 2007 | -11.4 | -125.78% |
| 2006 | 44.3 | -260.21% |
| 2005 | -27.6 | -50.42% |
| 2004 | -55.8 | 572.34% |
| 2003 | -8.29 | 222.41% |
| 2002 | -2.57 | -81.84% |
| 2001 | -14.2 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | 36.7 | -1,066.07% | 🇺🇸 USA |
 Agilent Technologies A | 34.3 | -1,003.59% | 🇺🇸 USA |
 Quest Diagnostics
DGX | 20.6 | -642.76% | 🇺🇸 USA |
 Danaher DHR | 31.5 | -929.87% | 🇺🇸 USA |
 PerkinElmer
PKI | 15.0 | -494.12% | 🇺🇸 USA |
 Translate Bio
TBIO.defunct | N/A | N/A | 🇺🇸 USA |
 Pacific Biosciences
PACB | -1.53 | -59.77% | 🇺🇸 USA |
 Luminex LMNX | N/A | N/A | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.